Sunmax Biotechnology Co., Ltd.

NT$390.50As of Sun 8 Nov 2026, 12:00 UTC
TPEx:4728Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR 28.03%
Div yield 3.10%
ROE 60.67%
Biotechnology
Beta (5Y) (0.11)
PE TTM 26.24
TSR TTM 3.28%
Mkt cap NT$21.27B
ROIC 186.31%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$373
(4.61%)
(77.77%)
Buy 10|9|11|1|0
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
4.18
4.38
4.71
5.13
3.91%
11.35%
10.57%
23.07%
RevenueNT$B
2.293
2.269
2.322
2.271
(0.93%)
(2.29%)
(1.51%)
(2.26%)
Peers (US$642.4M)
Cap (US$)
PE
651.0M
354.8x
486.7M
—
Capital
TTM
5Y
10Y
Leveragex
0.850
0.063
0.066
EBIT/Intx
1.524
0.588
0.718
Own earn%
(111.22)
238.62
172.41
Sh yield%
42.50
7.50
7.42
Owners
Insiders/Inst%
0.62
28.65
Short interest%
2.45
SBC / revenue%
0.53
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
4
Op margin range%
3–7
$1 testx
—
Incr. ROIC%
−4